2008

May Pharmacogenetics
— Background and future potential (PDF 170K)
— Current applications (PDF 80K)

Questions (PDF 70K) and Answers

April Valvular heart disease
— Pathophysiology and management (PDF 90K)
— Preventing thrombosis and endocarditis (PDF 80K)

Questions (PDF 40K) and Answers

February Skin cancer
— Identification and primary prevention (PDF 130K)
— Surgical and medical management (PDF 60K)

Questions (PDF 40K) and Answers

January Healthcare-associated infection
— Hospital-acquired infection (PDF 60K)
— Intervention-related infection (PDF 50K)
— Home intravenous therapy (PDF 60K)

Questions (PDF 40K) and Answers

2007

December Drug withdrawal
— The most common problems (PDF 50K)
— Patient management (PDF 60K)

Questions (PDF 40K) and Answers

November Urological emergencies
— Causes, symptoms and management (PDF 100K)
— Pharmacological treatment (PDF 60K)

Questions (PDF 70K) and Answers

October Acute coronary syndromes
— Assessment and interventions (PDF 200K)
— Pharmacological treatment (PDF 60K)

Questions (PDF 40K) and Answers

September Anorexia-cachexia
— The condition and its causes (PDF 70K)
— Pharmacological management (PDF 60K)
— Improving the patient experience (PDF 50K)

Questions (PDF 40K) and Answers

July/August Electronic prescribing
— Implications for hospital pharmacy (PDF 80K)
— Developing the solution (PDF 50K)
— Improving patient safety: an audit (PDF 50K)

Questions (PDF 70K) and Answers

June Nausea and vomiting
— Causes and complications (PDF 60K)
— Pharmacological management (PDF 60K)

Questions (PDF 70K) and Answers

May Macular degeneration
— Symptoms and diagnosis (PDF 80K)
— Advances in treatment (PDF 60K)

Questions (PDF 40K) and Answers

April Hypertension
— Clinical features and investigations (PDF 80K)
— Pharmacological management (PDF 80K)

Questions (PDF 40K) and Answers

February Statistical analysis
Analysing data — choosing appropriate statistical methods (PDF 410K)
Interpreting data — assessing study results and reports (PDF 140K)

Questions (PDF 80K) and Answers

January Poisoning
— an overview of treatment (PDF 100K)
— antidotes and their use (PDF 130K)

Questions (PDF 80K) and Answers

2006

December Procuring medicines (for the NHS)
Key issues for all pharmacy staff (PDF 100K)
Recent changes in England (PDF 280K)
Principles and practice of e-commerce (PDF 80K)

Questions (PDF 110K) and Answers

November Nutrition in hospital
Undernutrition in hospital — causes and consequences (PDF 60K)
Peri-operative nutrition — the role of the pharmacist (PDF 60K)
Hospital food policies — progress and improvements (PDF 50K)

Questions (PDF 80K) and Answers

October Fungal infections
— causes and diagnosis (PDF 90K)
— pharmacological therapy (PDF 60K)

Questions (PDF 80K) and Answers

September Acromegaly
— clinical manifestations and diagnosis (PDF 1 MB)
— treatment options and management (PDF 240K)

Questions (PDF 110K) and Answers

July/August Peptic ulcer disease
— disease and non-drug treatment (PDF 70K)
— pharmacological treatment (PDF 60K)

Questions (PDF 40K) and Answers

June Venous thromboembolism
— manifestations and diagnosis (PDF 60K)
— treatment and prophylaxis (PDF 60K)

Questions (PDF 40K) and Answers

May Inflammatory bowel disease
— disease and its diagnosis (PDF 60K)
— drug treatment and its implications (PDF 70K)

Questions (PDF 40K) and Answers

April Anxiety disorders
— disease and non-drug treatment (PDF 70K)
— pharmacological management (PDF 60K)

Questions (PDF 50K) and Answers

March Tuberculosis
— diagnosis and investigation (PDF 70K)
— pharmacological management (PDF 70K)

Questions (PDF 50K) and Answers

February Health economics
— an introduction to the methodology (PDF 90K)
— the models used for health economic analysis (PDF 90K)
— the evaluation and application of pharmacoeconomic studies (PDF 100K)

Questions (PDF 80K) and Answers

January Pulmonary hypertension
— the condition and specialist assessment (PDF 100K)
— treatment options (PDF 80K)

Questions (PDF 80K) and Answers

2005

November Gout
— the disease and non-drug treatment PDF (140K)
— pharmacological management PDF (140K)

Questions (PDF 80K) and Answers

October Lymphatic malignancies
— Hodgkin’s lymphoma PDF (150K)
— non-Hodgkin’s lymphoma PDF (190K)

Questions (PDF 80K) and Answers

September Radiopharmacy
— Clinical use of the products PDF (120K)
— Problems encountered with the products PDF (90K)
— Overcoming the training barriers PDF (120K)

Questions (PDF 80K) and Answers

July/August Glaucoma
— the pathophysiology and diagnosis PDF (180K)
— pharmacological treatment PDF (140K)

Questions (PDF 70K) and Answers

June Cystic fibrosis
— the disease PDF (140K)
— pharmacological treatment PDF (180K)

Questions (PDF 80K) and Answers

May Dyslipidaemia
— the condition and non-drug treatment PDF (120K)
— drug treatment PDF (120K)

Questions (PDF 80K) and Answers

April Lung cancer
— the disease and non-drug treatment PDF (140K)
— the role of chemotherapy PDF (120K)

Questions (PDF 80K) and Answers

March Spinal cord injury
— the condition and its acute management PDF (150K)
— medium- and long-term management PDF (130K)

Questions (PDF 80K) and Answers

February Arrhythmias
— overview of the condition PDF (310K)
— the options for treatment PDF (120K)

Questions (PDF 80K) and Answers

January Clinical nutrition
— physiology and treatment of intestinal failure PDF (120K)
— using nutraceuticals in critical care PDF (85K)
— pharmacist prescribing of parenteral nutrition PDF (85K)

Questions (PDF 100K) and Answers

2004

November Breast cancer
— overview of the disease (PDF 75K)
— treatment of early disease (PDF 90K)

Questions (PDF 80K) and Answers

 Acrobat Reader

Life-long learning competition

Winners & runners up (2007)
January to July/August
September to November

A continuing professional development (CPD) series was launched in the November 2004 issue of Hospital Pharmacist. It is designed to help readers use the monthly special features to contribute towards their CPD. It is expected that CPD will become mandatory for practising pharmacists during 2005.

The Life-long Learning series replaces Credit for Learning which was discontinued in May. Life-long Learning will be a regular feature of Hospital Pharmacist, running in 10 issues per year.

As part of the new series, specialist pharmacy groups, such as the British Oncology Pharmacy Association, are to be invited to become more involved in developing the special features. It is also hoped that they will be able to contribute to the identifying knowledge gaps section, a key focus of CPD.

The College of Pharmacy Practice will continue to provide accreditation of the questions. This means that college members can make completion part of their compulsory continuing education requirement.

Pharmacists completing the answer grid will be able to send it off to be marked. A certificate of completion and list of model answers will be returned.